Skip to main content
. 2016 Apr 9;7(18):26823–26836. doi: 10.18632/oncotarget.8662

Figure 2. Kaplan-Meier survival curves of DFS and OS based on CEA/Cyfra21–1 levels in EGFR del19 or L858R adenocarcinoma patients.

Figure 2

DFS (A) and OS (B) based on CEA level in del19 adenocarcinoma patients; DFS (C) and OS (D) based on Cyfra21–1 level in del19 adenocarcinoma patients; DFS (E) and OS (F) based on CEA level in L858R adenocarcinoma patients; DFS (G) and OS (H) based on Cyfra21–1 level in L858R adenocarcinoma patients.